Bifogade filer
Swedencare Annual Report 2023
Kurs
-0,94%
Likviditet
2,79 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-07-23 | 07:30 | Kvartalsrapport 2025-Q2 |
| 2025-04-24 | - | Årsstämma |
| 2025-04-24 | 07:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | 07:30 | Bokslutskommuniké 2024 |
| 2024-10-23 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-25 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | X-dag ordinarie utdelning SECARE 0.23 SEK |
| 2024-04-25 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-25 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-27 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-02 | - | X-dag ordinarie utdelning SECARE 0.22 SEK |
| 2023-04-28 | - | Årsstämma |
| 2023-04-28 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-10-19 | - | Extra Bolagsstämma 2022 |
| 2022-07-28 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-29 | - | X-dag ordinarie utdelning SECARE 0.20 SEK |
| 2022-04-28 | - | Årsstämma |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-28 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-29 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-24 | - | Split SECARE 1:5 |
| 2021-04-30 | - | X-dag ordinarie utdelning SECARE 0.80 SEK |
| 2021-04-29 | - | Årsstämma |
| 2021-04-29 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-09-11 | - | Extra Bolagsstämma 2020 |
| 2020-07-24 | - | Kvartalsrapport 2020-Q2 |
| 2020-04-22 | - | X-dag ordinarie utdelning SECARE 0.70 SEK |
| 2020-04-21 | - | Årsstämma |
| 2020-04-21 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-13 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-26 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-26 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
| 2019-04-25 | - | Årsstämma |
| 2019-04-25 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-26 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-25 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
| 2018-04-24 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-10-26 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
| 2017-04-27 | - | Årsstämma |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
The annual report for Swedencare AB for the year 2023 is now published and available on the company's website https://swedencare.com/investors/ as well as attached.
For more information, please contact:
Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 01 70
Email: hakan.lagerberg@swedencare.se
Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 85 54
Email: jenny.graflind@swedencare.se
FNCA is the Certified Adviser of the Company
Please visit the Company homepage www.swedencare.com
About Swedencare
Swedencare, a listed company on NASDAQ First North Growth Market, develops, produces and sells premium products in the global and fast-growing market for healthcare products for cats, dogs and horses. The company has an extensive product portfolio with strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, and ProDen PlaqueOff®, the original for good oral health. Swedencare’s headquarter is in Malmö, Sweden and the company's products are currently sold in approximately sixty-five countries to veterinarians, pet stores, and online through a distribution network, including subsidiaries in nine countries and an international network of retailers. Swedencare's sales have increased significantly over several years with maintained high profitability.